Ph.Eur. 2.6.14. Bacterial endotoxins

The European Pharmacopoeia (Ph. Eur.) Chapter 2.6.14, (harmonized with USP <85> and JP 4.01 under ICH Q4B Annex 14) "Bacterial Endotoxins," provides methods for detecting and quantifying endotoxins from gram-negative bacteria. This critical quality control test ensures the safety of parenteral pharmaceuticals and medical devices by limiting exposure to endotoxins, which can cause fever and other severe physiological reactions.

This chapter defines the Limulus Amebocyte Lysate (LAL) test methods (gel-clot, turbidimetric, chromogenic) and the required validation steps ensuring that the product matrix does not inhibit or enhance endotoxin detection.

Ph. Eur. 2.6.14 applies to:

• Parenteral drug products
• Some raw materials and water systems where endotoxin limits apply
• Certain medical devices when required by regulatory authority or monograph

The chapter is used when a monograph or regulatory commitment specifies the Bacterial Endotoxins Test (BET).

Core Principle:
The test detects and quantifies bacterial endotoxins (lipopolysaccharides, LPS) via the clotting cascade of an amoebocyte lysate obtained from Limulus polyphemus or Tachypleus tridentatus (recombinant factor C (rFC) assays are described separately in Ph. Eur. 2.6.32 as validated alternatives to LAL) The reaction is triggered by the lipid A portion of LPS, producing measurable turbidity or color change.

Harmonized Test Methods:

• Method A — Gel-Clot: Limit Test
  Qualitative; requires formation of a firm gel.
• Method B — Gel-Clot: Semi-Quantitative Test
  Provides a dilution-based estimate of endotoxin concentration.
• Method C — Turbidimetric Kinetic Method
  Quantitative; measures the rate of turbidity increase as the clotting cascade proceeds.
• Method D — Chromogenic Kinetic Method
  Quantitative; measures the rate of chromophore release as the reaction proceeds.
• Method E — Chromogenic End-Point Method
  Quantitative; measures the final absorbance after the chromogenic reaction has completed.
• Method F — Turbidimetric End-Point Method
  Quantitative; measures the final turbidity after the reaction has completed.

All methods are considered harmonized across Ph. Eur., USP <85>, and JP 4.01 under ICH Q4B Annex 14 when applied according to each compendium.

Validation and Preparatory Testing:
Before routine testing:

1. Lysate Sensitivity Check

Verify the labeled sensitivity (λ) using Reference Standard Endotoxin (RSE) traceable to compendial standards.

2. Inhibition/Enhancement Test (IET)

Confirm that the product does not:

inhibit endotoxin detection

artificially enhance the response

This is required for each product and method.

3. Standard Curve / Linear Range (for quantitative methods)

Ensure acceptable linearity, accuracy, and precision.

Endotoxin Limit Calculation

The maximum allowable endotoxin level is calculated using:

Endotoxin Limit (EU/mL)=K/M​​

where:

K = Maximum allowable endotoxin exposure

• For parenterals: typically 5 EU/kg
• For intrathecal products: 0.2 EU/kg

M = Maximum dose per kg body weight per hour

These values are defined in pharmacopeial text and regulatory guidance.